Selective estrogen receptor modulators: Established and new drugs;Selektive östrogenrezeptormodulatoren (SERMs): Bewährte und neue substanzen

Gynakologische Endokrinologie

Volumn 6, Issue 4, 2008, Pages 205-212

  Schaudig, K ^a,b   Schwenkhagen, A ^a,b  

^a Gynaekologicum Hamburg ^*  (Germany)

^b Universitat Schleswig Holstein   (Germany)

Author keywords

Breast cancer; Estrogen receptor; Osteoporosis; Selective estrogen receptor modulators; Tissue selective

Indexed keywords

ACOLBIFENE; ARZOXIFENE; BAZEDOXIFENE; CENTCHROMAN; CLOMIFENE; DROLOXIFENE; ENCLOMIFENE; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; HMR 3339; IDOXIFENE; LASOFOXIFENE; OSPEMIFENE; PIPENDOXIFENE; PLACEBO; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TOREMIFENE; UNCLASSIFIED DRUG; ZUCLOMIFENE;

BREAST CARCINOMA; CLINICAL TRIAL; DRUG EFFECT; ENDOMETRIUM CARCINOMA; HORMONAL THERAPY; HUMAN; HYPERPLASIA; HYSTERECTOMY; INVASIVE CARCINOMA; POSTMENOPAUSE OSTEOPOROSIS; RECEPTOR BINDING; REVIEW;

EID: 56549128635     PISSN: 16102894     EISSN: 16102908     Source Type: Journal    
DOI: 10.1007/s10304-008-0266-5     Document Type: Review

References (38)

1. Abrams 2001 J Natl Cancer Inst 93 662
2. Barrett-Connor 2006 N Eng J Med 355 125
3. Beck 2005 Cochrane Database Syst Rev 2005 1 CD002249
4. Carpenter 2006 Ann N Y Acad Sci 1092 361
5. Chang 1996 Ann Oncol 7 671
6. Christodoulakos 2006 Ann N Y Acad Sci 1092 374
7. Cohen 1999 Gynecol Oncol 72 202
8. Cuzick 2007 J Natl Cancer Inst 99 272
9. Cuzick 2003 Lancet 361 296
10. Delmas 2002 J Clin Endocrinol Metab 87 3609
11. Dickey 1996 Hum Reprod Update 2 483
12. Early 2005 Lancet 351 1451
13. Ettinger 1999 JAMA 282 637
14. Fabian 2004 Clin Cancer Res 10 5403
15. Fisher 1998 J Natl Cancer Inst 90 1371
16. Fisher 2007 J Natl Cancer Inst 97 1652
17. Goldstein 2006 Menopause 13 325
18. Gruber 2002 N Engl J Med 346 340
19. Harvey 2006 Breast 15 142
20. Jordan 2008 Eur J Cancer 44 30
21. Kharode Y, Bodine PV, Miller CP et al. (2008) The pairing of a selective estrogen receptor modulator, bazedoxifene, With conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention. Endocrinology (Epub ahead of print)
22. Komi 2005 Menopause 12 202
23. Martino 2004 J Natl Cancer Inst 96 1751
24. McClung 2006 Menopause 13 377
25. Mendelsohn 1999 N Engl J Med 340 1801
26. Mourits 1999 Gynecol Oncol 73 21
27. Munster 2006 Expert Opin Investig Drugs 15 317
28. Powles 2007 J Natl Cancer Inst 99 283
29. Riggs 2003 N Engl J Med 348 618
30. Ronkin 2005 Obstet Gynecol 105 1397
31. Sato 1994 J Bone Miner Metab 12 S9
32. Shelly 2008 Obstet Gynecol Survey 63 163
33. Silverman SL, Christiansen C, Genant HK et al. (2008) Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo- and active-controlled clinical trial. J Bone Miner Res (Epub ahead of print)
34. Spelsberg 1999 Mol Endocrinol 13 819
35. Vergote 2006 Ann Oncol 17 200
36. Veronesi 2007 J Natl Cancer Inst 99 727
37. Vogel 2006 JAMA 295 2727
38. Wierman 2007 Advan Physiol Educ 31 26